General
The State of New Mexico should mandate insurance carriers within the state to cover
The State of New Mexico should mandate insurance carriers within the state to cover medications prescribed by physicians for stimulant use disorder that have shown to be effective, are still in trial, and have otherwise had an improved outcome in reducing the use of methamphetamines.
2022 Submitted Public Comment to the CDC Clinical Practice Guideline for Prescribing Opioids